Generative Optogenetics (GO) DARPA-PS-26-10
Summary
AI-generated · Dec 20, 2025Design a protein complex that can be expressed in living cells and, when exposed to optical signals, directly synthesize a corresponding DNA or RNA sequence. This template-free mechanism would allow the massless transfer of genetic information to cells expressing the protein, with nucleotide bases incorporated in response to specific light wavelengths. The program focuses on two Research Objectives: (1) achieving in vivo DNA/RNA synthesis guided by optical signals, and (2) developing error-mitigation methods to ensure high-fidelity nucleic acid synthesis.
Submissions will proceed in two stages: first, written abstracts to screen concepts, and then invitations to submit an Oral Proposal Package (OPP) for an in-person briefing at DARPA.
The Defense Advanced Research Projects Agency (DARPA) is soliciting innovative concepts to design a protein complex that can be expressed in vivo (i.e., in a living cell) and responds to optical signals to synthesize a corresponding DNA or RNA sequence. This technology should enable massless transfer of genetic information to cells expressing the protein complex via a template-free mechanism that incorporates nucleotide bases in response to specific optical signals (e.g., different wavelengths of light). The GO program is focused on two main Research Objectives (ROs): (1) achieving the core capability of synthesizing DNA/RNA directly in living cells using optical signals, and (2) developing error mitigation methods that ensure high-fidelity nucleic acid synthesis. The acquisition process for GO will proceed through a two-stage process, starting with (1) written abstracts which will inform invitations to brief (2) an Oral Proposal Package (OPP) at DARPA.
From Solicitation posted on Dec 19, 2025Notice history
1-
Solicitation LATEST Posted Dec 19, 2025
Details
Award Information
Not yet awarded